Over the past 12 months, 12 insiders at TEVA PHARMACEUTICAL INDUSTRIES LTD filed 43 open-market SEC Form 4 transactions on TEVA: 1 purchase worth $21K and 42 sales worth $83.9M. Insiders have been net sellers over this period. The most recent filing was on Jun 11, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 26 | Eliyahu Sharon KalifEVP, Chief Financial Officer | SELL | 106.6K | $34.10 | $3.6M |
| Jun 5, 26 | Richard D FrancisPresident and CEO | SELL | 6.2K | $34.35 | $211K |
| May 5, 26 | Richard DaniellEVP, Europe Commercial | SELL | 30.0K | $35.40 | $1.1M |
| Apr 30, 26 | Christine FoxEVP, U.S. Commercial | SELL | 21.3K | $35.31 | $751K |
| Mar 17, 26 | Mark Sabag"See ""Remarks""" | SELL | 62.1K | $30.14 | $1.9M |
| Mar 5, 26 | Richard DaniellEVP, Europe Commercial | SELL | 17.3K | $31.67 | $548K |
| Mar 5, 26 | Christine FoxEVP, U.S. Commercial | SELL | 7.9K | $31.67 | $251K |
| Mar 5, 26 | Richard D FrancisPresident and CEO | SELL | 20.0K | $31.67 | $634K |
| Mar 5, 26 | Eric A Hughes"See ""Remarks""" | SELL | 9.5K | $31.67 | $302K |
| Mar 5, 26 | Placid Jover"See ""Remarks""" | SELL | 14.2K | $31.67 | $448K |
| Mar 5, 26 | Brian SavageInterim Chief Legal Officer | SELL | 1.1K | $31.67 | $36K |
| Mar 5, 26 | Matthew ShieldsEVP, Global Operations | SELL | 17.3K | $31.67 | $548K |
| Mar 4, 26 | Richard DaniellEVP, Europe Commercial | SELL | 37.4K | $32.95 | $1.2M |
| Mar 4, 26 | Christine FoxEVP, U.S. Commercial | SELL | 9.1K | $32.46 | $295K |
| Mar 4, 26 | Richard D FrancisPresident and CEO | SELL | 23.4K | $32.46 | $759K |
| Mar 4, 26 | Eric A Hughes"See ""Remarks""" | SELL | 11.3K | $32.46 | $366K |
| Mar 4, 26 | Brian SavageInterim Chief Legal Officer | SELL | 1.5K | $32.46 | $48K |
| Mar 3, 26 | Richard DaniellEVP, Europe Commercial | SELL | 66.7K | $32.36 | $2.2M |
| Mar 3, 26 | Richard D FrancisPresident and CEO | SELL | 412.0K | $32.36 | $13.3M |
| Mar 3, 26 | Eric A Hughes"See ""Remarks""" | SELL | 68.7K | $32.36 | $2.2M |
| Mar 3, 26 | Brian SavageInterim Chief Legal Officer | SELL | 1.3K | $32.36 | $41K |
| Feb 26, 26 | Eliyahu Sharon KalifEVP, Chief Financial Officer | SELL | 345.8K | $33.64 | $11.6M |
| Feb 15, 26 | Richard D FrancisPresident and CEO | SELL | 286.1K | $34.22 | $9.8M |
| Dec 16, 25 | Roberto MignoneDirector | SELL | 77.4K | $30.24 | $2.3M |
| Dec 16, 25 | Amir WeissChief Accounting Officer | SELL | 12.3K | $30.20 | $371K |
| Dec 9, 25 | Richard DaniellExec. VP, European Commercial | SELL | 115.5K | $28.68 | $3.3M |
| Dec 9, 25 | Mark Sabag"See ""Remarks""" | SELL | 118.7K | $28.75 | $3.4M |
| Nov 26, 25 | Roberto MignoneDirector | SELL | 50.0K | $26.03 | $1.3M |
| Nov 20, 25 | Christine FoxEVP, Head of U.S. Commercial | SELL | 28.2K | $24.78 | $700K |
| Nov 14, 25 | Christine FoxEVP, Head of U.S. Commercial | SELL | 30.0K | $25.11 | $753K |
| Nov 6, 25 | Roberto MignoneDirector | SELL | 200.0K | $24.11 | $4.8M |
| Nov 6, 25 | Amir WeissChief Accounting Officer | SELL | 12.3K | $24.44 | $301K |
| Sep 5, 25 | David R. McAvoyEVP, Chief Legal Officer | BUY | 1.1K | $18.86 | $21K |
| Aug 1, 25 | Eric A Hughes"See ""Remarks""" | SELL | 52.7K | $15.16 | $800K |
| Aug 1, 25 | Placid Jover"See ""Remarks""" | SELL | 6.1K | $15.16 | $92K |
| Jun 12, 25 | Eliyahu Sharon KalifEVP, Chief Financial Officer | SELL | 55.8K | $17.08 | $953K |
| Jun 3, 25 | Matthew ShieldsEVP, Global Operations | SELL | 6.2K | $17.02 | $106K |
| May 8, 25 | Mark Sabag"See ""Remarks""" | SELL | 337.9K | $18.04 | $6.1M |
| Mar 5, 25 | Richard DaniellExec. VP, European Commercial | SELL | 48.4K | $15.91 | $769K |
| Mar 5, 25 | Christine FoxEVP, Head of U.S. Commercial | SELL | 2.1K | $15.91 | $34K |
| Mar 5, 25 | Richard D FrancisPresident and CEO | SELL | 8.3K | $15.91 | $131K |
| Mar 5, 25 | Eric A Hughes"See ""Remarks""" | SELL | 8.1K | $15.91 | $129K |
| Mar 5, 25 | David R. McAvoyEVP, Chief Legal Officer | SELL | 1.7K | $15.91 | $27K |
| Mar 4, 25 | Richard DaniellExec. VP, European Commercial | SELL | 56.4K | $15.73 | $887K |
| Mar 4, 25 | Christine FoxEVP, Head of U.S. Commercial | SELL | 4.0K | $15.73 | $63K |
| Mar 4, 25 | Richard D FrancisPresident and CEO | SELL | 15.5K | $15.73 | $244K |
| Mar 4, 25 | Eric A Hughes"See ""Remarks""" | SELL | 15.2K | $15.73 | $239K |
| Mar 4, 25 | David R. McAvoyEVP, Chief Legal Officer | SELL | 3.1K | $15.73 | $50K |
| Mar 3, 25 | Richard DaniellExec. VP, European Commercial | SELL | 49.3K | $16.19 | $798K |
| Mar 3, 25 | Richard D FrancisPresident and CEO | SELL | 24.9K | $16.19 | $403K |
Over the past 12 months, insiders at TEVA PHARMACEUTICAL INDUSTRIES LTD filed 1 open-market purchase worth $21K and 42 sales worth $83.9M on TEVA, which makes them net sellers over the period. The most recent Form 4 was filed on Jun 11, 26.
The largest recent open-market TEVA insider purchase in our data was $21K by David R. McAvoy, EVP, Chief Legal Officer, filed on Sep 5, 25.
12 different insiders at TEVA PHARMACEUTICAL INDUSTRIES LTD filed open-market SEC Form 4 transactions on TEVA over the last 12 months.
InsiderTape plots every TEVA insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every TEVA PHARMACEUTICAL INDUSTRIES LTD insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →